IN2013MN00758A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MN00758A IN2013MN00758A IN758MUN2013A IN2013MN00758A IN 2013MN00758 A IN2013MN00758 A IN 2013MN00758A IN 758MUN2013 A IN758MUN2013 A IN 758MUN2013A IN 2013MN00758 A IN2013MN00758 A IN 2013MN00758A
- Authority
- IN
- India
- Prior art keywords
- therapeutic agent
- devices
- implants
- antibodies
- months
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40893410P | 2010-11-01 | 2010-11-01 | |
US201161470299P | 2011-03-31 | 2011-03-31 | |
PCT/US2011/058774 WO2012061377A1 (fr) | 2010-11-01 | 2011-11-01 | Dispositifs à base de silicium pouvant être biologiquement érodés pour administration d'agents thérapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MN00758A true IN2013MN00758A (fr) | 2015-06-12 |
Family
ID=46024803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN758MUN2013 IN2013MN00758A (fr) | 2010-11-01 | 2011-11-01 |
Country Status (11)
Country | Link |
---|---|
US (3) | US9333173B2 (fr) |
EP (1) | EP2635255B1 (fr) |
JP (2) | JP6026424B2 (fr) |
CN (4) | CN104622790A (fr) |
AU (2) | AU2011323524B2 (fr) |
CA (1) | CA2816576C (fr) |
HK (3) | HK1210048A1 (fr) |
IN (1) | IN2013MN00758A (fr) |
RU (1) | RU2640918C2 (fr) |
TW (1) | TWI615150B (fr) |
WO (1) | WO2012061377A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
JP5858906B2 (ja) | 2009-05-04 | 2016-02-10 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 多孔質シリコン薬物溶出粒子 |
EP2635255B1 (fr) | 2010-11-01 | 2019-08-21 | EyePoint Pharmaceuticals US, Inc. | Dispositifs à base de silicium pouvant être biologiquement érodés pour administration d'agents thérapeutiques |
WO2014165097A1 (fr) * | 2013-03-12 | 2014-10-09 | Psivida Us, Inc. | Dispositif d'administration de médicament comprenant des particules de transport à base de silicium |
US20140271764A1 (en) * | 2013-03-12 | 2014-09-18 | Psivida Us, Inc. | Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents |
RU2705986C2 (ru) * | 2013-03-15 | 2019-11-13 | Айпоинт Фармасьютикалз Юэс, Инк. | Биоразлагаемые композиции на основе кремния для доставки терапевтических агентов |
WO2016044366A1 (fr) * | 2014-09-16 | 2016-03-24 | Psivida Us, Inc. | Compositions et méthodes pour la libération contrôlée d'agents |
JP6883257B2 (ja) * | 2017-05-16 | 2021-06-09 | 株式会社豊田中央研究所 | 還元反応用固体触媒 |
JP2021531327A (ja) | 2018-06-19 | 2021-11-18 | セラ セラピューティクス エルエルシー | 眼圧降下剤、cnp化合物、nrp−b化合物、tie−2アゴニスト、または神経栄養剤を含む、緑内障または高眼圧症を治療するための徐放性薬剤送達系 |
JP2021531328A (ja) | 2018-06-19 | 2021-11-18 | セラ セラピューティクス エルエルシー | 神経栄養剤、アポトーシスシグナリング断片化阻害剤(FAS)もしくはFASリガンド(FASL)阻害剤、腫瘍壊死因子α(TNF−α)もしくはTNF受容体阻害剤、ミトコンドリアペプチド、オリゴヌクレオチド、ケモカイン阻害剤、またはシステイン−アスパラギン酸プロテアーゼを含む薬剤送達系 |
TWI803092B (zh) * | 2021-04-01 | 2023-05-21 | 逢甲大學 | 具負載與釋放活性成分的奈米粒子、其製造方法與眼用裝置之應用 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3832458A (en) | 1971-12-06 | 1974-08-27 | River C Foundation | Hydrophilic silicone composition and method |
US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
US3919723A (en) | 1974-05-20 | 1975-11-18 | Friedrichsfeld Gmbh | Bone shaft or bone joint prosthesis and process |
US3919060A (en) | 1974-06-14 | 1975-11-11 | Ibm | Method of fabricating semiconductor device embodying dielectric isolation |
DE3214667C2 (de) | 1982-04-21 | 1985-07-18 | Akzo Gmbh, 5600 Wuppertal | Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen |
JPS59101145A (ja) | 1982-11-30 | 1984-06-11 | 日本特殊陶業株式会社 | 薬液含浸多孔質セラミツクス |
JPS59131346A (ja) | 1983-01-17 | 1984-07-28 | 日本特殊陶業株式会社 | 薬液含浸多孔質セラミツクスの製造法 |
DE3423667A1 (de) | 1984-05-08 | 1985-11-28 | Rüdiger Dipl.-Ing. 5204 Lohmar Scheunemann | Implantat fuer knochen- und zahnwurzelersatz mit spezieller uebergangsstruktur zwischen knochen und implantatkern und knochenseitig ganz oder teilweise resorbierbarer matrix |
GB8422876D0 (en) | 1984-09-11 | 1984-10-17 | Secr Defence | Silicon implant devices |
US4608048A (en) | 1984-12-06 | 1986-08-26 | Alza Corporation | Dispensing device with drug delivery patterns |
US5057082A (en) | 1988-11-04 | 1991-10-15 | Plastic Injectors, Inc. | Trocar assembly |
WO1990011070A1 (fr) | 1989-03-17 | 1990-10-04 | Pitman-Moore, Inc. | Dispositif d'administration par liberation controlee de proteines macromoleculaires |
US5167625A (en) | 1990-10-09 | 1992-12-01 | Sarcos Group | Multiple vesicle implantable drug delivery system |
NZ247392A (en) * | 1992-04-30 | 1995-05-26 | Takeda Chemical Industries Ltd | Prefilled syringe containing two substances mixed before injection |
US5366454A (en) | 1993-03-17 | 1994-11-22 | La Corporation De L'ecole Polytechnique | Implantable medication dispensing device |
US5370630A (en) | 1993-11-12 | 1994-12-06 | Smidebush; Michael J. | Device for injection of fluidic materials into body tissue |
US5489266A (en) * | 1994-01-25 | 1996-02-06 | Becton, Dickinson And Company | Syringe assembly and method for lyophilizing and reconstituting injectable medication |
US5558071A (en) | 1994-03-07 | 1996-09-24 | Combustion Electromagnetics, Inc. | Ignition system power converter and controller |
US5817327A (en) | 1994-07-27 | 1998-10-06 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US5591453A (en) | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US5665114A (en) | 1994-08-12 | 1997-09-09 | Meadox Medicals, Inc. | Tubular expanded polytetrafluoroethylene implantable prostheses |
US5792099A (en) | 1995-02-14 | 1998-08-11 | Decamp; Dennis | Syringe and cannula for insertion of viscoelastic material into an eye and method of using same |
EP0818990A1 (fr) | 1995-04-03 | 1998-01-21 | Abbott Laboratories | Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente |
US6096344A (en) | 1995-07-28 | 2000-08-01 | Advanced Polymer Systems, Inc. | Bioerodible porous compositions |
GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
US5665428A (en) | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
DE19608423A1 (de) | 1996-03-05 | 1997-09-11 | Merck Patent Gmbh | Implantate mit phasenweiser Arzneistoffabgabe |
FR2749169B1 (fr) * | 1996-06-04 | 1998-08-21 | Delab | Procede pour constituer une preparation injectable et dispositif pour la mise en oeuvre de ce procede |
US5797898A (en) | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US7070590B1 (en) | 1996-07-02 | 2006-07-04 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
US5922299A (en) | 1996-11-26 | 1999-07-13 | Battelle Memorial Institute | Mesoporous-silica films, fibers, and powders by evaporation |
JP3217286B2 (ja) * | 1996-12-19 | 2001-10-09 | 科学技術振興事業団 | Dna固定化複合体 |
AU2460099A (en) | 1998-01-20 | 1999-08-02 | Drexel University | Mesoporous materials and methods of making the same |
US6696258B1 (en) | 1998-01-20 | 2004-02-24 | Drexel University | Mesoporous materials and methods of making the same |
US6060036A (en) | 1998-02-09 | 2000-05-09 | Implant Sciences Corporation | Radioactive seed implants |
GB9808052D0 (en) * | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
GB9815819D0 (en) | 1998-07-22 | 1998-09-16 | Secr Defence | Transferring materials into cells and a microneedle array |
ES2251251T3 (es) | 1998-12-23 | 2006-04-16 | Alza Corporation | Formas farmaceuticas que comprenden particulas porosas. |
EP1154691A4 (fr) * | 1999-01-05 | 2004-07-07 | Massachusetts Eye & Ear Infirm | Administration ciblee de medicament a liberation regulee vers la retine et la choroide a travers la sclerotique |
WO2001012221A1 (fr) * | 1999-08-16 | 2001-02-22 | Henceforth Hibernia, Inc. | Compositions therapeutiques et prophylactiques contenant des solides biomimetiques catalytiques et procedes de preparation et d'utilisation de celles-ci |
GB9924334D0 (en) | 1999-10-15 | 1999-12-15 | Secr Defence | Pharmaceutical products and methods of fabrication therefor |
IL149004A0 (en) | 1999-10-18 | 2002-11-10 | Ferx Inc | Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
SE9903958D0 (sv) | 1999-11-02 | 1999-11-02 | Boerje Sellergren | Porous materials for selective binding or transport of molecular guests |
US6521284B1 (en) | 1999-11-03 | 2003-02-18 | Scimed Life Systems, Inc. | Process for impregnating a porous material with a cross-linkable composition |
AUPQ573300A0 (en) | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
PT1278518E (pt) | 2000-02-28 | 2007-01-31 | Pfizer Entpr Sarl | Composição sinergetica para o tratamento do cancro colorectal |
IL134830A0 (en) | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
KR20030009389A (ko) | 2000-03-14 | 2003-01-29 | 브루카드 괴케 | 유문동-유문-십이지장 운동성에 대한 글루카곤 유사펩티드-1 (7-36)의 효과 |
GB0008494D0 (en) | 2000-04-07 | 2000-05-24 | Secr Defence | Microprojectile delivery system |
GB2365769A (en) | 2000-08-18 | 2002-02-27 | Secr Defence | Skin preparations containing silicon |
GB0104383D0 (en) | 2001-02-22 | 2001-04-11 | Psimedica Ltd | Cancer Treatment |
WO2002096389A1 (fr) | 2001-05-30 | 2002-12-05 | Microchips, Inc. | Dispositifs reservoirs a micropuce pourvus d'un revetement conforme |
WO2004018360A1 (fr) | 2002-08-23 | 2004-03-04 | Mcmaster University | Procedes et composes destines a reguler la morphologie et le retrecissement de silice derivee de silanes a polyol modifie |
CN1301692C (zh) | 2002-09-18 | 2007-02-28 | 阿勒根公司 | 眼植入物导入的器械 |
WO2004071949A2 (fr) | 2003-02-13 | 2004-08-26 | The Regents Of The University Of California | Moulage nanostructure de polymeres organiques et de biopolymeres dans des matrices de silicium poreux |
US7433811B2 (en) | 2003-05-06 | 2008-10-07 | The Regents Of The University Of California | Direct patterning of silicon by photoelectrochemical etching |
US7563451B2 (en) | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
GB0324483D0 (en) * | 2003-10-21 | 2003-11-19 | Psi Medica Ltd | Composite material |
EP1694307A2 (fr) | 2003-10-21 | 2006-08-30 | PSIMEDICA Limited | Methodes de traitement du cancer |
US20050181049A1 (en) | 2003-11-19 | 2005-08-18 | Dong Liang C. | Composition and method for enhancing bioavailability |
JP2008513127A (ja) | 2004-09-17 | 2008-05-01 | オルムコ コーポレイション | 医療装置及び針製造方法 |
US20060067979A1 (en) | 2004-09-30 | 2006-03-30 | Bausch & Lomb Incorporated | Ophthalmic drug release device for multiple drug release |
WO2006037160A1 (fr) * | 2004-10-05 | 2006-04-13 | The University Of Melbourne | Materiaux de polyelectrolyte poreux |
EP3381446A1 (fr) | 2004-10-29 | 2018-10-03 | The Regents of The University of California | Cristaux photoniques poreux pour l'administration de médicaments oculaires |
WO2006067979A1 (fr) | 2004-12-21 | 2006-06-29 | Nec Corporation | Boitier pour dispositif electrique a enveloppe par film |
JP2007091716A (ja) | 2005-08-29 | 2007-04-12 | Kuraray Co Ltd | 水中薬剤徐放性微粒子及びその製造方法 |
GB0526332D0 (en) | 2005-12-23 | 2006-02-01 | Psimedica Ltd | Pharmaceutical product |
WO2007106868A2 (fr) * | 2006-03-14 | 2007-09-20 | University Of Rochester | dispositifs de culture cellulaire ayant une membrane ultra-poreuse et leurs utilisations |
US7998497B2 (en) | 2006-03-31 | 2011-08-16 | Qlt Inc. | Nasolacrimal drainage system implants for drug therapy |
JP4984644B2 (ja) * | 2006-05-19 | 2012-07-25 | 株式会社ジェイ・エム・エス | 注射装置 |
US20080057102A1 (en) * | 2006-08-21 | 2008-03-06 | Wouter Roorda | Methods of manufacturing medical devices for controlled drug release |
EP2066699B1 (fr) | 2006-09-25 | 2020-02-12 | Archer-Daniels-Midland Company | Polysaccharides carboxyalkylés traités en surface au moyen d'un superabsorbant et leur procédé de production |
JP5141948B2 (ja) * | 2007-07-09 | 2013-02-13 | 株式会社豊田中央研究所 | バイモダルな細孔構造を有する球状シリカ系メソ多孔体及びその製造方法 |
CA2696139C (fr) * | 2007-07-10 | 2018-04-17 | The Regents Of The University Of California | Materiaux et methodes d'administration de compositions dans des tissus selectionnes |
US20130084243A1 (en) | 2010-01-27 | 2013-04-04 | Liliane Goetsch | Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
EP2326306A1 (fr) | 2008-09-25 | 2011-06-01 | Cephalon, Inc. | Formulations liquides de bendamustine |
GB0817938D0 (en) * | 2008-09-30 | 2008-11-05 | Intrinsiq Materials Global Ltd | Cosmetic formulations |
GB0817936D0 (en) * | 2008-09-30 | 2008-11-05 | Intrinsiq Materials Global Ltd | Porous materials |
JP5369725B2 (ja) | 2009-01-30 | 2013-12-18 | 株式会社ニコン | 撮像装置 |
WO2010090596A1 (fr) * | 2009-02-04 | 2010-08-12 | Agency For Science, Technology And Research | Particule creuse de silice avec un polymère sur celle-ci |
WO2010096733A2 (fr) | 2009-02-20 | 2010-08-26 | The Regents Of The University Of California | Nanoparticules de silicium poreuses luminescentes, leurs procédés de production et d'utilisation |
US20100247607A1 (en) | 2009-03-26 | 2010-09-30 | Psivida Us, Inc. | Implantable formulations of bisphosphonic acids |
JP5382700B2 (ja) * | 2009-03-27 | 2014-01-08 | 独立行政法人産業技術総合研究所 | ロッド状多孔質シリカ粒子 |
JP5858906B2 (ja) * | 2009-05-04 | 2016-02-10 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 多孔質シリコン薬物溶出粒子 |
US20110028412A1 (en) | 2009-08-03 | 2011-02-03 | Cappellos, Inc. | Herbal enhanced analgesic formulations |
DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
GB201017048D0 (en) | 2010-10-08 | 2010-11-24 | Ucl Business Plc | Composition |
EP2635255B1 (fr) | 2010-11-01 | 2019-08-21 | EyePoint Pharmaceuticals US, Inc. | Dispositifs à base de silicium pouvant être biologiquement érodés pour administration d'agents thérapeutiques |
US20120238993A1 (en) | 2010-12-22 | 2012-09-20 | Martin Nazzaro | Two-piece injectable drug delivery device with heat-cured seal |
RU2013138180A (ru) | 2011-02-11 | 2015-03-20 | Псивида Юэс, Инк. | Способы лечения макулярного отека с использованием противоотечных лекарственных средств |
BR112013025157A2 (pt) | 2011-03-31 | 2019-09-24 | Galderma Res & Dev | composições compreendendo um produto de carga e pelo menos um material com base em sílica bioabsorvível e biodegradável |
CN103889401B (zh) | 2011-08-29 | 2017-10-13 | Qlt公司 | 持续释放递送活性剂以治疗青光眼和高眼压 |
US10011574B2 (en) | 2012-11-21 | 2018-07-03 | Agios Pharmaceuticals, Inc. | Glutaminase inhibitors and method of use |
US20140271764A1 (en) | 2013-03-12 | 2014-09-18 | Psivida Us, Inc. | Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents |
WO2016077632A2 (fr) | 2014-11-13 | 2016-05-19 | Buck Institute For Research On Aging | Inhibition du catabolisme de la proline pour le traitement du cancer et d'autres applications thérapeutiques |
-
2011
- 2011-11-01 EP EP11838672.1A patent/EP2635255B1/fr active Active
- 2011-11-01 JP JP2013536924A patent/JP6026424B2/ja not_active Expired - Fee Related
- 2011-11-01 AU AU2011323524A patent/AU2011323524B2/en not_active Ceased
- 2011-11-01 CN CN201410827969.6A patent/CN104622790A/zh active Pending
- 2011-11-01 TW TW100139841A patent/TWI615150B/zh not_active IP Right Cessation
- 2011-11-01 CN CN201410826616.4A patent/CN104622789A/zh active Pending
- 2011-11-01 US US13/286,788 patent/US9333173B2/en active Active
- 2011-11-01 IN IN758MUN2013 patent/IN2013MN00758A/en unknown
- 2011-11-01 RU RU2013119438A patent/RU2640918C2/ru active
- 2011-11-01 CA CA2816576A patent/CA2816576C/fr not_active Expired - Fee Related
- 2011-11-01 WO PCT/US2011/058774 patent/WO2012061377A1/fr active Application Filing
- 2011-11-01 CN CN201180056566.0A patent/CN103282020B/zh active Active
- 2011-11-01 CN CN201410822342.1A patent/CN104586742A/zh active Pending
-
2015
- 2015-11-06 HK HK15110964.4A patent/HK1210048A1/xx unknown
- 2015-11-12 HK HK15111163.1A patent/HK1210416A1/xx unknown
- 2015-11-12 HK HK15111162.2A patent/HK1210415A1/xx unknown
-
2016
- 2016-02-04 JP JP2016019772A patent/JP6189460B2/ja not_active Expired - Fee Related
- 2016-05-05 US US15/147,203 patent/US11026885B2/en active Active
- 2016-10-20 US US15/299,050 patent/US9808421B2/en active Active
- 2016-11-16 AU AU2016259330A patent/AU2016259330B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP6026424B2 (ja) | 2016-11-16 |
RU2013119438A (ru) | 2014-12-10 |
JP2016121173A (ja) | 2016-07-07 |
AU2016259330A1 (en) | 2016-12-08 |
US20160243276A1 (en) | 2016-08-25 |
TW201306867A (zh) | 2013-02-16 |
AU2011323524B2 (en) | 2016-12-08 |
AU2016259330B2 (en) | 2018-11-08 |
US20120177695A1 (en) | 2012-07-12 |
CA2816576C (fr) | 2020-06-02 |
RU2640918C2 (ru) | 2018-01-12 |
US11026885B2 (en) | 2021-06-08 |
EP2635255B1 (fr) | 2019-08-21 |
US9333173B2 (en) | 2016-05-10 |
EP2635255A4 (fr) | 2016-11-09 |
CN104622789A (zh) | 2015-05-20 |
WO2012061377A1 (fr) | 2012-05-10 |
CN103282020A (zh) | 2013-09-04 |
HK1210048A1 (en) | 2016-04-15 |
CN104622790A (zh) | 2015-05-20 |
US20170035690A1 (en) | 2017-02-09 |
AU2011323524A1 (en) | 2013-05-23 |
CA2816576A1 (fr) | 2012-05-10 |
JP6189460B2 (ja) | 2017-08-30 |
TWI615150B (zh) | 2018-02-21 |
HK1210415A1 (en) | 2016-04-22 |
JP2013541562A (ja) | 2013-11-14 |
CN104586742A (zh) | 2015-05-06 |
CN103282020B (zh) | 2016-10-26 |
US9808421B2 (en) | 2017-11-07 |
EP2635255A1 (fr) | 2013-09-11 |
HK1210416A1 (en) | 2016-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MN00758A (fr) | ||
MX2020011786A (es) | Oligomeros antisentido para tratamiento de afecciones y enfermedades. | |
CY1119192T1 (el) | Μεθοδος κρυσταλλωσης και βιοδιαθεσιμοτητα | |
GB2465677B (en) | Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes | |
GB2471588A (en) | Therapeutic peptidomimetic macrocycles | |
NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
EP3192526A3 (fr) | Exosomes d'administration d'agents biothérapeutiques | |
EP1971288A4 (fr) | Dispositif micronise d'administration de molecules biologiquement actives et procede d'utilisation | |
IL211952A (en) | A transplantable device for providing risperidone and methods for its use | |
MX354444B (es) | Dispositivos implantables heterogeneos para suministro de medicamento. | |
NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
MX339125B (es) | Endoprotesis de metal desnudo con receptaculos eluyentes de farmacos. | |
PT2210588E (pt) | Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana | |
UA108885C2 (uk) | Композиція рисперидону для ін'єкційної депо-форми | |
LT2013015A (lt) | Farmacinės kompozicijos | |
MX340636B (es) | Dispositivo oftalmico que tiene capacidad de liberacion de agentes terapeuticos y metodos para formar el mismo. | |
MX352824B (es) | Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación. | |
IL210545A (en) | Transplantation devices for use of octreotide transport and use of octreotide to create drugs | |
WO2012037519A3 (fr) | Accélération de la cicatrisation des plaies par l'hormone de libération de l'hormone de croissance et ses agonistes | |
MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
MX367070B (es) | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. | |
MX2014001393A (es) | 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-on as sustituidas. | |
MX2015011775A (es) | Uso de levocetirizina y montelukast en el tratamiento de anafilaxis. | |
MX351282B (es) | Stent de metal sin recubrir con depósitos de elución de fármaco que tiene retención de fármaco mejorada. | |
EA201790382A1 (ru) | Способы лечения периимплантита |